Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:24 PM
Ignite Modification Date: 2025-12-24 @ 5:24 PM
NCT ID: NCT02916550
Eligibility Criteria: Inclusion Criteria: * Age 18 to 80 * BMI 17 to 35 * Proficient in English language * Paroxysmal atrial fibrillation or ventricular fibrillation or frequent premature atrial/ventricular contractions Exclusion Criteria: * No telephone access * Active suicidal ideation with intent or plan * Active drug or alcohol dependence, or active binge drinking within the last month * Cardiovascular instability, as evidenced any of the following: 1. New York Heart Association (NHYA) heart failure class IV (i.e., unable to carry on any physical activity without discomfort, symptoms of heart failure at rest, increased discomfort with any physical activity is undertaken) 2. American College of Cardiology/American Heart Association congestive heart failure stage D (i.e., heart failure symptoms at rest, receiving end of life care). 3. Unstable angina or exercise induced angina 4. Persistent atrial fibrillation * Pacemakers or combined pacemaker/ICDs will be excluded * Presence of unstable cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic, or metabolic disease; or any other condition that, in the opinion of the investigator, would make participation not be in the best interest (e.g., compromise the well-being) of the subject or that could prevent, limit, or confound the protocol-specified assessments.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 80 Years
Study: NCT02916550
Study Brief:
Protocol Section: NCT02916550